Anti-CTLA-4 antibody, although not effective by itself against larger tumors, can restore the anti-tumor efficacy of CpG + OX40 in larger A20 lymphomas but not in larger B78 melanomas. This evidence concerns the gene TNFRSF4 and neoplasm.